Craig Russell

Home » Experts » Craig Russell

Lecturer, Pharmacy, Aston University

In 2010 I completed my degree in Human Biology at the University of Huddersfield and began my PhD at Aston focusing on medicines research. Here, formulation of oral liquid antihypertensives formed the initial stages of my project; here an understanding of drug action on a molecular level in a physiological setting was essential. In vitro and In vivo characterisation of developed formulations utilising cell and rodent based models paved the way for subsequent genomic investigations into intestinal transporter expression profiling using microarray technology and bioinformatics. Following my PhD I worked as a postdoctoral research fellow at Aston on a project focused on in vitro assessment of taste and was carried out in collaboration with market leading pharmaceutical companies AstraZeneca, GSK, Pfizer and Bristol Myers Squib as well as UCL. During this time I also elevated my teaching profile and arrived at Aston University as a Lecturer in Pharmacy in 2015. Since my lectureship appointment I have been heavily involved with teaching on the MPharm degree programme and I am pursuing my own line of research in formulation design and development. I have recently been awarded funding internally for a PhD studentship investigating the application of 3D printing technology in tablet production which commenced in January 2018. More recent research tracks have seen innovation in the application of nanoparticle formulations to better target administration in hospital settings.

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

By Dr Duane Mellor, Craig Russell, Clinical A/Prof Srikanth Bellary

Clinical Articles

Diabetes and metabolism

Craig Russell

Lecturer, Pharmacy, Aston University

More from this expert

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.

Craig Russell

Lecturer, Pharmacy, Aston University

More from this expert

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.